Replies to post #598971 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

So sell the news

[bas2020]

Are you saying that there's nothing wrong with NVCR's trial or the CEO that the usual highly-critical, nefarious bunch can spin up... like they do with NWBO? That's truly unbelievable!

[dennisdave]

This is what is happening to many biotechs over the last few years its a common trap, and NWBO was not the only one. As a matter of fact, I wrote about this phenomenon 14 months ago and was of course shut down here.

Longs load up on anticipation of TLD, then an attack on the SP after positive TLD, Longs then panic and start selling to pocket their gains from the last weeks in anticipation of TLD. Short sellers who started the panic cover their short position. I read an extensive article about it in Yahoo Finance two years ago. It works really well because many longs think they can have a nice gain after TLD and there are no longs who want to buy after the fact of TLD.

[Dan88]

Ignorant at best and ill wished at worst. In today's news about NVCR "positive" lung cancer trial results, It shows that "only 2% of patients in the ICI arm had prior ICI exposure while in the real world, 99% of patients get ICI treatment. A flawed trial with crooked results as usual for NVCR.

Get things straight. [so it's not sell on news but instead sell on bad news]

[CrashOverride]

Bullshit trial per usual from Novocure.

[GPha]

If you did a comparative analysis of the previous clinical trials regarding the median overall survival (mOS) in patients with non-small cell lung cancer (NSCLC) you will have endless inquiries on NVCR trial. Nonetheless, look at their PFS results as well.